Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Detalles Bibliográficos
Autores principales: Wei, Xuan, Shi, Juanjuan, Lin, Qianhan, Ma, Xiaoxue, Pang, Yingxin, Mao, Hongluan, Li, Rui, Lu, Wei, Wang, Yu, Liu, Peishu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453349/
https://www.ncbi.nlm.nih.gov/pubmed/34557417
http://dx.doi.org/10.3389/fonc.2021.742374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453349/
https://www.ncbi.nlm.nih.gov/pubmed/34557417
http://dx.doi.org/10.3389/fonc.2021.742374

Ejemplares similares